Article: A Patient With CAD Deficiency Responsive to Uridine and Literature Review

CAD encodes a multifunctional enzyme involved in pyrimidine biosynthesis, and pyrimidine can be alternatively recycled from uridine. Trio whole-exome sequencing identified CAD compound heterozygous mutations in a new male patient with global developmental delay (DD), refractory epilepsy, and anemia with anisopoikilocytosis. We further reviewed all published cases with CAD deficiency. Five patients were collected from two publications, including three males and two females, and all presented with DD, drug-resistant epilepsy, and anemia with anisopoikilocytosis. Four out of six patients (including the present case) were supplemented with uridine, which led to immediate cessation of seizures, resolved anemia with anisopoikilocytosis, and progress in global development. The other two patients, who were not treated with uridine, died at the ages of 4 and 5 years. In summary, CAD deficiency is probably a treatable neurometabolic disorder.

Citing Articles

Novel CAD gene mutations in a boy with developmental and epileptic encephalopathy 50 with dramatic response to uridine therapy: a case report and a review of the literature.

Duan L, Ye L, Yin R, Sun Y, Yu W, Zhang Y BMC Pediatr. 2024; 24(1):160.

PMID: 38454370 PMC: 10921618. DOI: 10.1186/s12887-024-04593-6.

Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.

Del Cano-Ochoa F, Ng B, Rubio-Del-Campo A, Mahajan S, Wilson M, Vilar M J Inherit Metab Dis. 2023; 46(6):1170-1185.

PMID: 37540500 PMC: 10838372. DOI: 10.1002/jimd.12667.

Nutrition interventions in congenital disorders of glycosylation.

Boyer S, Johnsen C, Morava E Trends Mol Med. 2022; 28(6):463-481.

PMID: 35562242 PMC: 9375550. DOI: 10.1016/j.molmed.2022.04.003.

A Treatable Genetic Disease Caused by CAD Mutation.

Peng X, Xia L, Zhang H, Zhang J, Yu S, Wang S Front Pediatr. 2022; 10:771374.

PMID: 35356445 PMC: 8959624. DOI: 10.3389/fped.2022.771374.

Uridine monophosphate (UMP)-responsive developmental and epileptic encephalopathy: A case report of two siblings and a review of literature.

Al-Otaibi A, AlAyed A, Al Madhi A, Saeed L, Ng B, Freeze H Mol Genet Metab Rep. 2022; 30:100835.

PMID: 35242569 PMC: 8856910. DOI: 10.1016/j.ymgmr.2021.100835.

References

1.

Wurtman R, Ulus I, Cansev M, Watkins C, Wang L, Marzloff G . Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006; 1088(1):83-92. DOI: 10.1016/j.brainres.2006.03.019. View

2.

Ng B, Wolfe L, Ichikawa M, Markello T, He M, Tifft C . Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors. Hum Mol Genet. 2015; 24(11):3050-7. PMC: 4424951. DOI: 10.1093/hmg/ddv057. View

3.

Chen K, Vannais D, Jones C, Patterson D, Davidson J . Mapping of the gene encoding the multifunctional protein carrying out the first three steps of pyrimidine biosynthesis to human chromosome 2. Hum Genet. 1989; 82(1):40-4. DOI: 10.1007/BF00288269. View

4.

Huang M, Graves L . De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cell Mol Life Sci. 2003; 60(2):321-36. PMC: 11146060. DOI: 10.1007/s000180300027. View

5.

Chen S, Bigner S, Modrich P . High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc Natl Acad Sci U S A. 2001; 98(24):13802-7. PMC: 61122. DOI: 10.1073/pnas.241508098. View